Ocugen Analyst Ratings
Maxim Group Initiates Ocugen(OCGN.US) With Buy Rating, Announces Target Price $4
Ocugen (OCGN) Receives a Buy From Noble Financial
Buy Rating on Ocugen: Strong Financials and Promising Clinical Progress
Noble Financial Sticks to Their Buy Rating for Ocugen (OCGN)
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH) and Ocugen (OCGN)
Noble Financial Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $8
HC Wainwright & Co. : The Ocugen (OCGN.US) rating was reaffirmed and adjusted from buy to buy, and the target price was $7.00.
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Financials and Advancing Clinical Pipeline
Chardan Capital: Maintains Ocugen (OCGN.US) rating, adjusted from buy to buy rating, and adjusted target price from $4.00 to $5.00.
Ocugen Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Financial Stability
HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $7 Price Target
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Positive Financial Outlook
HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $7
Ocugen Analyst Ratings